文献速递药物不良反应与药物警戒

医疗器械安全治理:现状、挑战与未来监管方向

Navigating Medical Device Safety: Current Status, Challenges, and Future Regulatory Directions.
PubMed 文献 · Drug Saf · 2025-08-20

本文综述医疗器械安全现状,聚焦监管框架、报告系统及数据碎片化与漏报挑战,强调上市后监测(PMS)的关键作用,并探讨人工智能与区块链等新技术及国际协调对提升器械全生命周期安全监测的意义。

要点

  • 医疗器械复杂性增加,尤其含人工智能技术者,带来新的安全使用挑战。
  • 全球报告系统与监测实践存在差异,数据碎片化与漏报妨碍有效安全监管。
  • 上市后监测是识别风险、确保器械真实世界性能的关键环节。

核心结论

  • 需通过利用真实世界数据、加强网络安全与国际合作来应对医疗器械安全挑战并提升监管效率。

研究设计与样本

  • 本文为综述,探讨医疗器械安全现状、监管框架、报告系统及新兴技术应用与国际协调努力。

主要发现

  • 医疗器械漏洞可导致从轻微并发症到严重伤害或死亡的不良事件。
  • 与电子健康管理系统和互联网协议互联的器械健康风险日益增加。
  • 监管机构间报告系统与监测实践存在全球差异,阻碍有效安全监督。
  • 数据收集碎片化与漏报是当前医疗器械安全监测的主要挑战。
  • 人工智能用于预测性安全和区块链用于追溯,有望在器械生命周期早期加强监测并降低风险。

关键数值与推荐

  • 关键建议包括利用真实世界数据、加强网络安全措施、促进国际合作以简化监管流程。
  • 国际医疗器械监管机构论坛(IMDRF)、国际药物警戒学会(ISoP)和世界卫生组织(WHO)致力于标准化报告实践并改善全球协作。

临床怎么用

  • 临床药学智能体医生应关注医疗器械上市后监测数据,识别真实世界风险信号。
  • 在评估含人工智能或网络互联的医疗器械时,需重视网络安全与数据完整性风险。
  • 可借助真实世界数据与国际协调框架,支持器械相关不良事件的报告与风险沟通。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Medical devices are indispensable in modern healthcare. They enable the prevention, diagnosis, and treatment of diseases while enhancing patient outcomes. However, the increasing complexity of these devices, particularly those incorporating advanced technologies such as artificial intelligence (AI) introduces new challenges to their safe use. The vulnerabilities of medical devices can lead to adverse events ranging from minor complications to severe injuries or fatalities, and there is an increasing health risk to those devices that are interconnected to electronic health management systems and internet protocols. Despite efforts by regulatory authorities such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Health Canada, disparities in reporting systems and monitoring practices persist globally, hindering effective safety oversight. This paper explores the current landscape of medical device safety, focusing on regulatory frameworks, reporting systems, and the challenges posed by fragmented data collection and underreporting. It highlights the critical role of postmarket surveillance (PMS) in identifying risks and ensuring device performance in real-world settings. The integration of emerging technologies, such as AI for predictive safety and blockchain for traceability, offers promising solutions to enhance monitoring and mitigate risks early in the device lifecycle. In addition, the paper examines harmonization efforts led by organizations such as The International Medical Device Regulators Forum (IMDRF), the International Society of Pharmacovigilance (ISoP) and the World Health Organazition (WHO), which aim to standardize reporting practices and improve global collaboration. Key recommendations include leveraging real-world data, enhancing cybersecurity measures, and fostering international cooperation to streamline regulatory processes. By addressing these challenges and embracing innovation, stakeholders can ensure that medical devices continue to advance healthcare while maintaining the highest safety standards. Such collective efforts are essential for safeguarding patient trust and improving global health outcomes.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Aimer O, Baldridge C. Navigating Medical Device Safety: Current Status, Challenges, and Future Regulatory Directions. Drug Saf. 2025. PMID: 40833550. doi:10.1007/s40264-025-01599-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。